Natera completes $54.6M financing for global rollout of Panorama prenatal test

Wednesday, May 1, 2013

Natera, a genetic testing company, has completed a $54.6 million financing round to support the expansion and continued global rollout of Natera’s non-invasive prenatal test, Panorama. The financing round included two new lead investors, OrbiMed Advisors and Harmony Partners, as well as other undisclosed new investors. All existing investors participated, including Claremont Creek Ventures, Lightspeed Venture Partners, Founders Fund and Sequoia Capital.

[Read More]